Vivimed Labs Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDANANA
EBITNANA
Earning Per Share-9-7
Expenses838245
Net Profit-78-68
Net Profit Margin-9-29
Operating Profit Margin4-3
Profit Before Tax-76-65
Dividends Per ShareNANA
Operation Revenue871239

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of Vivimed Labs is NA as of 3/27/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20162017201820192022
Operating Activities154582142228
Investing Activities-190-68-164-89-16
Financing Activities4135186-338-10
Others00000
Net Cash Flow42544-51

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Vivimed Labs is 28 as of 3/27/2023